Smart hybrid materials equipped by nanoreservoirs of therapeutics.

ACS Nano

Institut National de la Santé et de la Recherche Médicale (INSERM), Unité 977, 11 rue Humann, 67085 Strasbourg, France.

Published: January 2012

Nanobiotechnology enables the emergence of entirely new classes of bioactive devices intended for targeted intracellular delivery for more efficacies and less toxicities. Among organic and inorganic approaches currently developed, controlled release from polymer matrices promises utmost clinical impact. Here, a unique nanotechnology strategy is used to entrap, protect, and stabilize therapeutic agents into polymer coatings acting as nanoreservoirs enrobing nanofibers of implantable membranes. Upon contact with cells, therapeutic agents become available through enzymatic degradation of the nanoreservoirs. As cells grow, divide, and infiltrate deeper into the porous membrane, they trigger slow and progressive release of therapeutic agents that, in turn, stimulate further cell proliferation. This constitutes the first instance of a smart living nanostructured hybrid membrane for regenerative medicine. The cell contact-dependent bioerodable nanoreservoirs described here will permit sustained release of drugs, genes, growth factors, etc., opening a general route to the design of sophisticated cell-therapy implants capable of robust and durable regeneration of a broad variety of tissues.

Download full-text PDF

Source
http://dx.doi.org/10.1021/nn203817tDOI Listing

Publication Analysis

Top Keywords

therapeutic agents
12
smart hybrid
4
hybrid materials
4
materials equipped
4
nanoreservoirs
4
equipped nanoreservoirs
4
nanoreservoirs therapeutics
4
therapeutics nanobiotechnology
4
nanobiotechnology enables
4
enables emergence
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!